Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Antiretroviral Therapy, Highly Active* ; Health Services Accessibility*; Coinfection/*transmission ; Coinfection/*virology ; HIV Infections/*virology ; Hepacivirus/*physiology ; Hepatitis C/*transmission; Adult ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Spain

Background: Maternal HIV coinfection is a key factor for mother-to-child transmission (MTCT) of HCV. However, data about HCV MTCT in HIV/HCV-coinfected pregnant women on combined antiretroviral treatment (ART) are scarce. This study assessed the HCV MTCT rate in the Madrid Cohort of HIV-infected women.
Methods: Retrospective study within the Madrid Cohort of HIV-infected pregnant women (2000-2012). Epidemiological, clinical and treatment related variables were analysed for the mother and infant pairs. HCV MTCT rate was determined.
Results: Three hundred thirty-nine HIV/HCV-coinfected women and their exposed infants were recorded. A total of 227 (67%) paired mother-children had available data of HCV follow-up and were included for the analysis. Sixteen children (rate 7.0%, 95%CI 3.7-10.4%) were HCV infected by 18 months of age, none of them coinfected with HIV. HIV/HCV-coinfected pregnant women were mostly of Spanish origin with a background of previous injection drug use. HCV-genotype 1 was predominant. The characteristics of mothers that transmitted HCV were similar to those that did not transmit HCV with respect to sociodemographic and clinical features. A high rate (50%) of preterm deliveries was observed. Infants infected with HCV were similar at birth in weight, length and head circumference than those uninfected.
Conclusion: MTCT rates of HCV among HIV/HCV-coinfected women on ART within the Madrid cohort were lower than previously described. However, rates are still significant and strategies to eliminate any HCV transmission from mother to child are needed.
Competing Interests: The authors have declared that no competing interests exist.

J Infect Dis. 2005 Dec 1;192(11):1872-9. (PMID: 16267757)
J Hepatol. 2014 Nov;61(1 Suppl):S45-57. (PMID: 25086286)
AIDS. 2007 Aug 20;21(13):1811-5. (PMID: 17690581)
Clin Infect Dis. 2007 Apr 15;44(8):1123-31. (PMID: 17366462)
Pediatr Infect Dis J. 2011 Sep;30(9):801-4. (PMID: 21772231)
J Hepatol. 2007 May;46(5):783-90. (PMID: 17321633)
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):439-450. (PMID: 29287028)
Pediatr Infect Dis J. 2012 Oct;31(10):1053-8. (PMID: 22926219)
Med Clin (Barc). 2016 Dec 2;147(11):499-505. (PMID: 27209226)
Hepatology. 2015 Dec;62(6):1656-8. (PMID: 26238474)
Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:173-7. (PMID: 26409061)
J Virus Erad. 2016 Jan 01;2(1):52-4. (PMID: 27482435)
Clin Infect Dis. 2014 Sep 15;59(6):765-73. (PMID: 24928290)
Lancet Gastroenterol Hepatol. 2019 Jun;4(6):477-487. (PMID: 30982721)
J Infect Dis. 1998 Oct;178(4):1047-52. (PMID: 9806033)
J Med Virol. 2009 May;81(5):836-43. (PMID: 19319981)
J Pediatric Infect Dis Soc. 2013 Jun;2(2):126-35. (PMID: 26199724)
Am J Obstet Gynecol. 2017 Nov;217(5):B2-B12. (PMID: 28782502)
J Pediatr. 2012 Nov;161(5):915-21. (PMID: 22765955)
World J Gastroenterol. 2012 Jan 14;18(2):99-104. (PMID: 22253515)
Clin Infect Dis. 2016 Apr 15;62(8):980-5. (PMID: 26797211)
J Viral Hepat. 2011 Apr;18(4):229-36. (PMID: 21392169)
J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):209-16. (PMID: 16877987)
Lancet. 2000 Sep 9;356(9233):904-7. (PMID: 11036896)
J Pediatr. 1995 Aug;127(2):278-80. (PMID: 7636656)

Date Created: 20200410 Date Completed: 20200701 Latest Revision: 20200701

20240105

PMC7144987

10.1371/journal.pone.0230109

32271775